These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


152 related items for PubMed ID: 2674426

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Lack of correlation between pharmacokinetics and efficacy of low dose methotrexate in patients with rheumatoid arthritis.
    Lafforgue P, Monjanel-Mouterde S, Durand A, Catalin J, Acquaviva PC.
    J Rheumatol; 1995 May; 22(5):844-9. PubMed ID: 8587070
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Stamp LK, O'Donnell JL, Chapman PT, Zhang M, Frampton C, James J, Barclay ML.
    Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis.
    Dalrymple JM, Stamp LK, O'Donnell JL, Chapman PT, Zhang M, Barclay ML.
    Arthritis Rheum; 2008 Nov; 58(11):3299-308. PubMed ID: 18975321
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy.
    Kremer JM, Petrillo GF, Hamilton RA.
    J Rheumatol; 1995 Jan; 22(1):38-40. PubMed ID: 7699678
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis.
    Buckley LM, Vacek PM, Cooper SM.
    J Rheumatol; 1990 Sep; 17(9):1158-61. PubMed ID: 2132565
    [Abstract] [Full Text] [Related]

  • 17. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M, Chladek J, Simkova M, Vaneckova J, Grim J, Martinkova J.
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of ingestion of ferrous sulfate on the absorption of oral methotrexate in patients with rheumatoid arthritis.
    Hamilton SF, Campbell NR, Kara M, Watson J, Connors M.
    J Rheumatol; 2003 Sep; 30(9):1948-50. PubMed ID: 12966595
    [Abstract] [Full Text] [Related]

  • 20. Is there an interaction between low doses of corticosteroids and methotrexate in patients with rheumatoid arthritis? A pharmacokinetic study in 33 patients.
    Lafforgue P, Monjanel-Mouterde S, Durand A, Catalin J, Acquaviva PC.
    J Rheumatol; 1993 Feb; 20(2):263-7. PubMed ID: 8474062
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.